Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosaminoglycan biosynthesis enzyme
- Molecular classification
- Enzyme, Glycosyltransferase (e.g., xylosyltransferase XT1/XT2, galactosyltransferases B4GALT7/B3GALT6, glucuronyltransferase B3GAT3), Sulfotransferase (e.g., CHST14, CHST15, NDST family), Epimerase (e.g., GLCE, DSE/DSEL), Kinase (e.g., FAM20B for phosphorylation), Polymerase (EXT1/EXT2, CHSY1/CHPF/CSGALNACT family)
01
Overview
Glycosaminoglycan biosynthesis enzymes are a collective group of enzymes—including glycosyltransferases, sulfotransferases, epimerases, and kinases—responsible for constructing and modifying glycosaminoglycan chains that are covalently attached to core proteins to form proteoglycans. These enzymes act sequentially, mainly in the Golgi apparatus, and dictate the structure, sulfation, and biological function of major GAG types such as heparan sulfate, chondroitin sulfate, dermatan sulfate, and keratan sulfate. Defects or dysregulation in these enzymes can result in a spectrum of connective tissue diseases, impact oncogenesis, and influence tissue remodeling and cell signaling.
- Other names
- GAG biosynthesis enzymeglycosyltransferase (subset)xylosyltransferasegalactosyltransferasesulfotransferaseepimerase (each refers to specific enzymes in the pathway)
02
Mechanism of action
Inhibition or enhancement of glycosyltransferase/sulfotransferase/epimerase activity Modification of GAG chain length or sulfation pattern, impacting ECM integrity, cell signaling, and disease phenotype Restoration of defective enzymatic function via supplementation or replacement (enzyme therapy)
03
Biological functions
Biosynthesis of glycosaminoglycans (structural component of proteoglycans)Cell signaling (modulation via proteoglycans and interaction with growth factors)Cell adhesionCell differentiationRegulation of cell proliferation and developmentMaintenance of extracellular matrix integrity and function
04
Disease associations
Cancer (expression and biosynthesis altered in various tumors)Neurodegenerative diseaseGenetic connective tissue diseases (e.g., GAG synthesis defects resulting in skeletal, skin, or neurological phenotypes)Skeletal dysplasia and cartilage disordersCardiovascular diseases (ECM-related roles)Inflammation (ECM remodeling and signaling)
05
Safety considerations
Off-target modulation can disrupt normal development and ECM integrity, with risk for skeletal deformities, skin and connective tissue disorders, and neurodevelopmental delayTherapeutic challenges include redundancy of enzyme functions, compensatory pathways in GAG biosynthesis, and broad tissue expression complicating targeted interventionsModulation may affect multiple cell types due to widespread ECM/proteoglycan roles
06
Interacting drugs
Enzyme replacement therapies (for rare genetic GAG biosynthesis disorders)
2 more in the full profile.
07
Biomarkers
Abnormal glycosaminoglycan patterns in blood/urine (diagnostic for inborn errors of metabolism)Enzymatic activity assays (for diagnosis and monitoring)Tissue or tumor-specific expression patterns of glycosyltransferase genes (e.g., EXT1, B4GALT7, XYLT1/2 in cancer/normal tissue profiling)
Beyond the preview
Go deeper on Glycosaminoglycan biosynthesis enzyme.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glycosaminoglycan biosynthesis enzyme.